0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunotherapy"

Gallbladder Cancer Market Report and Forecast 2024-2032 - Product Thumbnail Image

Gallbladder Cancer Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
EUR$4,969USDGBP
From
EUR$3,599USDGBP
Allogeneic T Cell Therapies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Allogeneic T Cell Therapies Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 160 Pages
  • Global
From
EUR$3,599USDGBP
From
EUR$4,949USDGBP
From
EUR$4,949USDGBP
From
EUR$4,949USDGBP
From
EUR$3,500USDGBP
From
EUR$3,500USDGBP
From
EUR$3,500USDGBP
From
EUR$3,500USDGBP
From
EUR$3,500USDGBP
From
EUR$4,500USDGBP
From
EUR$4,500USDGBP
From
EUR$4,500USDGBP
From
EUR$4,000USDGBP
From
EUR$4,500USDGBP
From
EUR$3,500USDGBP
From
EUR$4,500USDGBP
From
EUR$4,500USDGBP
Loading Indicator

Immunotherapy is a type of treatment used to treat immune disorders, such as allergies, asthma, and autoimmune diseases. It works by stimulating the body's own immune system to fight off disease-causing agents. Immunotherapy drugs are designed to target specific parts of the immune system, such as T-cells, B-cells, and cytokines. These drugs can be used to treat a variety of conditions, including cancer, HIV/AIDS, and rheumatoid arthritis. Immunotherapy drugs are typically administered through injections, infusions, or oral medications. They can also be used in combination with other treatments, such as chemotherapy or radiation therapy. The goal of immunotherapy is to reduce the severity of symptoms and improve the patient's quality of life. The immunotherapy market is a rapidly growing sector of the pharmaceutical industry. Companies in this market are focused on developing new treatments and therapies to treat immune disorders. Some of the major players in this market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more